Related Experiment Videos
Multiple endocrine neoplasia type 2
Mariola Peczkowska1, Andrzej Januszewicz
1Department of Hypertension, National Institute of Cardiology, Warsaw, Poland. peczpe@chello.pl
Abstract:
Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant inherited cancer syndrome. Predisposition to MEN 2 is caused by germline mutations of the RET proto-oncogene on chromosome 10q11.2 [1]. There are three clinically distinct forms of MEN 2 syndrome -- MEN 2A, familial medullary thyroid carcinoma (FMTC), and MEN 2B. In all of these subtypes, medullary thyroid carcinoma (MTC) is a key. MEN 2A is the most common subtype of MEN 2. Clinical features of the MEN 2A syndrome include medullary thyroid carcinoma (MTC) and/or C-cell hyperplasia (CCH) in almost all affected individuals, pheochromocytoma (approximately 50%) and hyperparathyroidism (HPT) (15-30%). MEN type 2B is the most aggressive of the MEN 2 variants and accounts for approximately 5% of all cases of MEN 2. MEN 2B is similar to MEN 2A but is characterized by the earlier onset of the disease and by developmental abnormalities. In FMTC, the third form of MEN 2, MTC is the only clinical feature. Introduced in recent years and still developing genetic testing of individuals at highest hereditary risk of MEN 2 syndrome holds the possibility of early detection and improved treatment and prognosis.
Insights
Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome caused by RET gene mutations. Genetic testing aids early detection and improves outcomes for MEN 2 subtypes like MEN 2A, FMTC, and MEN 2B.
Area of Science:
- Genetics
- Oncology
- Endocrinology
Background:
- Multiple Endocrine Neoplasia type 2 (MEN 2) is an autosomal dominant inherited cancer syndrome.
- Germline mutations in the RET proto-oncogene on chromosome 10q11.2 predispose individuals to MEN 2.
- MEN 2 encompasses three distinct subtypes: MEN 2A, familial medullary thyroid carcinoma (FMTC), and MEN 2B.
Purpose of the Study:
- To summarize the clinical characteristics and genetic basis of MEN 2.
- To highlight the significance of medullary thyroid carcinoma (MTC) across all MEN 2 subtypes.
- To emphasize the role of genetic testing in early detection and improved prognosis.
Main Methods:
- Review of existing literature on MEN 2.
- Analysis of clinical features associated with MEN 2 subtypes.
- Discussion of the genetic underpinnings of MEN 2.
Main Results:
- Medullary thyroid carcinoma (MTC) is a hallmark of all MEN 2 subtypes.
- MEN 2A, the most common form, involves MTC/C-cell hyperplasia, pheochromocytoma, and hyperparathyroidism.
- MEN 2B is the most aggressive, with early onset and developmental abnormalities; FMTC is characterized solely by MTC.
Conclusions:
- Genetic testing for RET proto-oncogene mutations is crucial for individuals at high risk.
- Early detection through genetic testing can lead to improved treatment and prognosis for MEN 2 patients.
- Understanding the distinct clinical features of MEN 2 subtypes facilitates tailored management strategies.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Type II Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Abnormal Proliferation